0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Long-term Asthma Control Medication Market Research Report 2025
Published Date: April 2025
|
Report Code: QYRE-Auto-37G13223
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Long term Asthma Control Medication Market Research Report 2023
BUY CHAPTERS

Global Long-term Asthma Control Medication Market Research Report 2025

Code: QYRE-Auto-37G13223
Report
April 2025
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Long-term Asthma Control Medication Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Long-term Asthma Control Medication Market

Long-term Asthma Control Medication Market

The global market for Long-term Asthma Control Medication was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Long-term Asthma Control Medication, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Long-term Asthma Control Medication.
The Long-term Asthma Control Medication market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Long-term Asthma Control Medication market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Long-term Asthma Control Medication companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Long-term Asthma Control Medication Market Report

Report Metric Details
Report Name Long-term Asthma Control Medication Market
CAGR 5%
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Pharmacy
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Boehringer Ingelheim, Mylan, GlaxoSmithKline, AstraZeneca, F. Hoffmann-La Roche, Merck & Co., Inc, Glenmark Pharmaceuticals, Teva Pharmaceutical Industries, Lupin Pharmaceuticals, Novartis International AG, Sunovion Pharmaceuticals, Sanofi
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Long-term Asthma Control Medication company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Long-term Asthma Control Medication Market report?

Ans: The main players in the Long-term Asthma Control Medication Market are Boehringer Ingelheim, Mylan, GlaxoSmithKline, AstraZeneca, F. Hoffmann-La Roche, Merck & Co., Inc, Glenmark Pharmaceuticals, Teva Pharmaceutical Industries, Lupin Pharmaceuticals, Novartis International AG, Sunovion Pharmaceuticals, Sanofi

What are the Application segmentation covered in the Long-term Asthma Control Medication Market report?

Ans: The Applications covered in the Long-term Asthma Control Medication Market report are Hospital, Clinic, Pharmacy

What are the Type segmentation covered in the Long-term Asthma Control Medication Market report?

Ans: The Types covered in the Long-term Asthma Control Medication Market report are Inhaled Type, Oral Type, Intravenous Injection Type

Recommended Reports

Asthma & Allergy Drugs

Allergy Treatment Therapies

Chronic Disease Medicines

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Long-term Asthma Control Medication Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Inhaled Type
1.2.3 Oral Type
1.2.4 Intravenous Injection Type
1.3 Market by Application
1.3.1 Global Long-term Asthma Control Medication Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Long-term Asthma Control Medication Market Perspective (2020-2031)
2.2 Global Long-term Asthma Control Medication Growth Trends by Region
2.2.1 Global Long-term Asthma Control Medication Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Long-term Asthma Control Medication Historic Market Size by Region (2020-2025)
2.2.3 Long-term Asthma Control Medication Forecasted Market Size by Region (2026-2031)
2.3 Long-term Asthma Control Medication Market Dynamics
2.3.1 Long-term Asthma Control Medication Industry Trends
2.3.2 Long-term Asthma Control Medication Market Drivers
2.3.3 Long-term Asthma Control Medication Market Challenges
2.3.4 Long-term Asthma Control Medication Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Long-term Asthma Control Medication Players by Revenue
3.1.1 Global Top Long-term Asthma Control Medication Players by Revenue (2020-2025)
3.1.2 Global Long-term Asthma Control Medication Revenue Market Share by Players (2020-2025)
3.2 Global Long-term Asthma Control Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Long-term Asthma Control Medication Revenue
3.4 Global Long-term Asthma Control Medication Market Concentration Ratio
3.4.1 Global Long-term Asthma Control Medication Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Long-term Asthma Control Medication Revenue in 2024
3.5 Global Key Players of Long-term Asthma Control Medication Head office and Area Served
3.6 Global Key Players of Long-term Asthma Control Medication, Product and Application
3.7 Global Key Players of Long-term Asthma Control Medication, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Long-term Asthma Control Medication Breakdown Data by Type
4.1 Global Long-term Asthma Control Medication Historic Market Size by Type (2020-2025)
4.2 Global Long-term Asthma Control Medication Forecasted Market Size by Type (2026-2031)
5 Long-term Asthma Control Medication Breakdown Data by Application
5.1 Global Long-term Asthma Control Medication Historic Market Size by Application (2020-2025)
5.2 Global Long-term Asthma Control Medication Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Long-term Asthma Control Medication Market Size (2020-2031)
6.2 North America Long-term Asthma Control Medication Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Long-term Asthma Control Medication Market Size by Country (2020-2025)
6.4 North America Long-term Asthma Control Medication Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Long-term Asthma Control Medication Market Size (2020-2031)
7.2 Europe Long-term Asthma Control Medication Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Long-term Asthma Control Medication Market Size by Country (2020-2025)
7.4 Europe Long-term Asthma Control Medication Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Long-term Asthma Control Medication Market Size (2020-2031)
8.2 Asia-Pacific Long-term Asthma Control Medication Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Long-term Asthma Control Medication Market Size by Region (2020-2025)
8.4 Asia-Pacific Long-term Asthma Control Medication Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Long-term Asthma Control Medication Market Size (2020-2031)
9.2 Latin America Long-term Asthma Control Medication Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Long-term Asthma Control Medication Market Size by Country (2020-2025)
9.4 Latin America Long-term Asthma Control Medication Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Long-term Asthma Control Medication Market Size (2020-2031)
10.2 Middle East & Africa Long-term Asthma Control Medication Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Long-term Asthma Control Medication Market Size by Country (2020-2025)
10.4 Middle East & Africa Long-term Asthma Control Medication Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Company Details
11.1.2 Boehringer Ingelheim Business Overview
11.1.3 Boehringer Ingelheim Long-term Asthma Control Medication Introduction
11.1.4 Boehringer Ingelheim Revenue in Long-term Asthma Control Medication Business (2020-2025)
11.1.5 Boehringer Ingelheim Recent Development
11.2 Mylan
11.2.1 Mylan Company Details
11.2.2 Mylan Business Overview
11.2.3 Mylan Long-term Asthma Control Medication Introduction
11.2.4 Mylan Revenue in Long-term Asthma Control Medication Business (2020-2025)
11.2.5 Mylan Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Long-term Asthma Control Medication Introduction
11.3.4 GlaxoSmithKline Revenue in Long-term Asthma Control Medication Business (2020-2025)
11.3.5 GlaxoSmithKline Recent Development
11.4 AstraZeneca
11.4.1 AstraZeneca Company Details
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Long-term Asthma Control Medication Introduction
11.4.4 AstraZeneca Revenue in Long-term Asthma Control Medication Business (2020-2025)
11.4.5 AstraZeneca Recent Development
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Company Details
11.5.2 F. Hoffmann-La Roche Business Overview
11.5.3 F. Hoffmann-La Roche Long-term Asthma Control Medication Introduction
11.5.4 F. Hoffmann-La Roche Revenue in Long-term Asthma Control Medication Business (2020-2025)
11.5.5 F. Hoffmann-La Roche Recent Development
11.6 Merck & Co., Inc
11.6.1 Merck & Co., Inc Company Details
11.6.2 Merck & Co., Inc Business Overview
11.6.3 Merck & Co., Inc Long-term Asthma Control Medication Introduction
11.6.4 Merck & Co., Inc Revenue in Long-term Asthma Control Medication Business (2020-2025)
11.6.5 Merck & Co., Inc Recent Development
11.7 Glenmark Pharmaceuticals
11.7.1 Glenmark Pharmaceuticals Company Details
11.7.2 Glenmark Pharmaceuticals Business Overview
11.7.3 Glenmark Pharmaceuticals Long-term Asthma Control Medication Introduction
11.7.4 Glenmark Pharmaceuticals Revenue in Long-term Asthma Control Medication Business (2020-2025)
11.7.5 Glenmark Pharmaceuticals Recent Development
11.8 Teva Pharmaceutical Industries
11.8.1 Teva Pharmaceutical Industries Company Details
11.8.2 Teva Pharmaceutical Industries Business Overview
11.8.3 Teva Pharmaceutical Industries Long-term Asthma Control Medication Introduction
11.8.4 Teva Pharmaceutical Industries Revenue in Long-term Asthma Control Medication Business (2020-2025)
11.8.5 Teva Pharmaceutical Industries Recent Development
11.9 Lupin Pharmaceuticals
11.9.1 Lupin Pharmaceuticals Company Details
11.9.2 Lupin Pharmaceuticals Business Overview
11.9.3 Lupin Pharmaceuticals Long-term Asthma Control Medication Introduction
11.9.4 Lupin Pharmaceuticals Revenue in Long-term Asthma Control Medication Business (2020-2025)
11.9.5 Lupin Pharmaceuticals Recent Development
11.10 Novartis International AG
11.10.1 Novartis International AG Company Details
11.10.2 Novartis International AG Business Overview
11.10.3 Novartis International AG Long-term Asthma Control Medication Introduction
11.10.4 Novartis International AG Revenue in Long-term Asthma Control Medication Business (2020-2025)
11.10.5 Novartis International AG Recent Development
11.11 Sunovion Pharmaceuticals
11.11.1 Sunovion Pharmaceuticals Company Details
11.11.2 Sunovion Pharmaceuticals Business Overview
11.11.3 Sunovion Pharmaceuticals Long-term Asthma Control Medication Introduction
11.11.4 Sunovion Pharmaceuticals Revenue in Long-term Asthma Control Medication Business (2020-2025)
11.11.5 Sunovion Pharmaceuticals Recent Development
11.12 Sanofi
11.12.1 Sanofi Company Details
11.12.2 Sanofi Business Overview
11.12.3 Sanofi Long-term Asthma Control Medication Introduction
11.12.4 Sanofi Revenue in Long-term Asthma Control Medication Business (2020-2025)
11.12.5 Sanofi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Long-term Asthma Control Medication Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Inhaled Type
 Table 3. Key Players of Oral Type
 Table 4. Key Players of Intravenous Injection Type
 Table 5. Global Long-term Asthma Control Medication Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Long-term Asthma Control Medication Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Long-term Asthma Control Medication Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Long-term Asthma Control Medication Market Share by Region (2020-2025)
 Table 9. Global Long-term Asthma Control Medication Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Long-term Asthma Control Medication Market Share by Region (2026-2031)
 Table 11. Long-term Asthma Control Medication Market Trends
 Table 12. Long-term Asthma Control Medication Market Drivers
 Table 13. Long-term Asthma Control Medication Market Challenges
 Table 14. Long-term Asthma Control Medication Market Restraints
 Table 15. Global Long-term Asthma Control Medication Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Long-term Asthma Control Medication Market Share by Players (2020-2025)
 Table 17. Global Top Long-term Asthma Control Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-term Asthma Control Medication as of 2024)
 Table 18. Ranking of Global Top Long-term Asthma Control Medication Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Long-term Asthma Control Medication Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Long-term Asthma Control Medication, Headquarters and Area Served
 Table 21. Global Key Players of Long-term Asthma Control Medication, Product and Application
 Table 22. Global Key Players of Long-term Asthma Control Medication, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Long-term Asthma Control Medication Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Long-term Asthma Control Medication Revenue Market Share by Type (2020-2025)
 Table 26. Global Long-term Asthma Control Medication Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Long-term Asthma Control Medication Revenue Market Share by Type (2026-2031)
 Table 28. Global Long-term Asthma Control Medication Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Long-term Asthma Control Medication Revenue Market Share by Application (2020-2025)
 Table 30. Global Long-term Asthma Control Medication Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Long-term Asthma Control Medication Revenue Market Share by Application (2026-2031)
 Table 32. North America Long-term Asthma Control Medication Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Long-term Asthma Control Medication Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Long-term Asthma Control Medication Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Long-term Asthma Control Medication Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Long-term Asthma Control Medication Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Long-term Asthma Control Medication Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Long-term Asthma Control Medication Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Long-term Asthma Control Medication Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Long-term Asthma Control Medication Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Long-term Asthma Control Medication Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Long-term Asthma Control Medication Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Long-term Asthma Control Medication Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Long-term Asthma Control Medication Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Long-term Asthma Control Medication Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Long-term Asthma Control Medication Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Boehringer Ingelheim Company Details
 Table 48. Boehringer Ingelheim Business Overview
 Table 49. Boehringer Ingelheim Long-term Asthma Control Medication Product
 Table 50. Boehringer Ingelheim Revenue in Long-term Asthma Control Medication Business (2020-2025) & (US$ Million)
 Table 51. Boehringer Ingelheim Recent Development
 Table 52. Mylan Company Details
 Table 53. Mylan Business Overview
 Table 54. Mylan Long-term Asthma Control Medication Product
 Table 55. Mylan Revenue in Long-term Asthma Control Medication Business (2020-2025) & (US$ Million)
 Table 56. Mylan Recent Development
 Table 57. GlaxoSmithKline Company Details
 Table 58. GlaxoSmithKline Business Overview
 Table 59. GlaxoSmithKline Long-term Asthma Control Medication Product
 Table 60. GlaxoSmithKline Revenue in Long-term Asthma Control Medication Business (2020-2025) & (US$ Million)
 Table 61. GlaxoSmithKline Recent Development
 Table 62. AstraZeneca Company Details
 Table 63. AstraZeneca Business Overview
 Table 64. AstraZeneca Long-term Asthma Control Medication Product
 Table 65. AstraZeneca Revenue in Long-term Asthma Control Medication Business (2020-2025) & (US$ Million)
 Table 66. AstraZeneca Recent Development
 Table 67. F. Hoffmann-La Roche Company Details
 Table 68. F. Hoffmann-La Roche Business Overview
 Table 69. F. Hoffmann-La Roche Long-term Asthma Control Medication Product
 Table 70. F. Hoffmann-La Roche Revenue in Long-term Asthma Control Medication Business (2020-2025) & (US$ Million)
 Table 71. F. Hoffmann-La Roche Recent Development
 Table 72. Merck & Co., Inc Company Details
 Table 73. Merck & Co., Inc Business Overview
 Table 74. Merck & Co., Inc Long-term Asthma Control Medication Product
 Table 75. Merck & Co., Inc Revenue in Long-term Asthma Control Medication Business (2020-2025) & (US$ Million)
 Table 76. Merck & Co., Inc Recent Development
 Table 77. Glenmark Pharmaceuticals Company Details
 Table 78. Glenmark Pharmaceuticals Business Overview
 Table 79. Glenmark Pharmaceuticals Long-term Asthma Control Medication Product
 Table 80. Glenmark Pharmaceuticals Revenue in Long-term Asthma Control Medication Business (2020-2025) & (US$ Million)
 Table 81. Glenmark Pharmaceuticals Recent Development
 Table 82. Teva Pharmaceutical Industries Company Details
 Table 83. Teva Pharmaceutical Industries Business Overview
 Table 84. Teva Pharmaceutical Industries Long-term Asthma Control Medication Product
 Table 85. Teva Pharmaceutical Industries Revenue in Long-term Asthma Control Medication Business (2020-2025) & (US$ Million)
 Table 86. Teva Pharmaceutical Industries Recent Development
 Table 87. Lupin Pharmaceuticals Company Details
 Table 88. Lupin Pharmaceuticals Business Overview
 Table 89. Lupin Pharmaceuticals Long-term Asthma Control Medication Product
 Table 90. Lupin Pharmaceuticals Revenue in Long-term Asthma Control Medication Business (2020-2025) & (US$ Million)
 Table 91. Lupin Pharmaceuticals Recent Development
 Table 92. Novartis International AG Company Details
 Table 93. Novartis International AG Business Overview
 Table 94. Novartis International AG Long-term Asthma Control Medication Product
 Table 95. Novartis International AG Revenue in Long-term Asthma Control Medication Business (2020-2025) & (US$ Million)
 Table 96. Novartis International AG Recent Development
 Table 97. Sunovion Pharmaceuticals Company Details
 Table 98. Sunovion Pharmaceuticals Business Overview
 Table 99. Sunovion Pharmaceuticals Long-term Asthma Control Medication Product
 Table 100. Sunovion Pharmaceuticals Revenue in Long-term Asthma Control Medication Business (2020-2025) & (US$ Million)
 Table 101. Sunovion Pharmaceuticals Recent Development
 Table 102. Sanofi Company Details
 Table 103. Sanofi Business Overview
 Table 104. Sanofi Long-term Asthma Control Medication Product
 Table 105. Sanofi Revenue in Long-term Asthma Control Medication Business (2020-2025) & (US$ Million)
 Table 106. Sanofi Recent Development
 Table 107. Research Programs/Design for This Report
 Table 108. Key Data Information from Secondary Sources
 Table 109. Key Data Information from Primary Sources
 Table 110. Authors List of This Report


List of Figures
 Figure 1. Long-term Asthma Control Medication Picture
 Figure 2. Global Long-term Asthma Control Medication Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Long-term Asthma Control Medication Market Share by Type: 2024 VS 2031
 Figure 4. Inhaled Type Features
 Figure 5. Oral Type Features
 Figure 6. Intravenous Injection Type Features
 Figure 7. Global Long-term Asthma Control Medication Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Long-term Asthma Control Medication Market Share by Application: 2024 VS 2031
 Figure 9. Hospital Case Studies
 Figure 10. Clinic Case Studies
 Figure 11. Pharmacy Case Studies
 Figure 12. Long-term Asthma Control Medication Report Years Considered
 Figure 13. Global Long-term Asthma Control Medication Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Long-term Asthma Control Medication Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Long-term Asthma Control Medication Market Share by Region: 2024 VS 2031
 Figure 16. Global Long-term Asthma Control Medication Market Share by Players in 2024
 Figure 17. Global Top Long-term Asthma Control Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-term Asthma Control Medication as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Long-term Asthma Control Medication Revenue in 2024
 Figure 19. North America Long-term Asthma Control Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Long-term Asthma Control Medication Market Share by Country (2020-2031)
 Figure 21. United States Long-term Asthma Control Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Long-term Asthma Control Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Long-term Asthma Control Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Long-term Asthma Control Medication Market Share by Country (2020-2031)
 Figure 25. Germany Long-term Asthma Control Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Long-term Asthma Control Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Long-term Asthma Control Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Long-term Asthma Control Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Long-term Asthma Control Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Long-term Asthma Control Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Long-term Asthma Control Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Long-term Asthma Control Medication Market Share by Region (2020-2031)
 Figure 33. China Long-term Asthma Control Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Long-term Asthma Control Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Long-term Asthma Control Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Long-term Asthma Control Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Long-term Asthma Control Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Long-term Asthma Control Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Long-term Asthma Control Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Long-term Asthma Control Medication Market Share by Country (2020-2031)
 Figure 41. Mexico Long-term Asthma Control Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Long-term Asthma Control Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Long-term Asthma Control Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Long-term Asthma Control Medication Market Share by Country (2020-2031)
 Figure 45. Turkey Long-term Asthma Control Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Long-term Asthma Control Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Long-term Asthma Control Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Boehringer Ingelheim Revenue Growth Rate in Long-term Asthma Control Medication Business (2020-2025)
 Figure 49. Mylan Revenue Growth Rate in Long-term Asthma Control Medication Business (2020-2025)
 Figure 50. GlaxoSmithKline Revenue Growth Rate in Long-term Asthma Control Medication Business (2020-2025)
 Figure 51. AstraZeneca Revenue Growth Rate in Long-term Asthma Control Medication Business (2020-2025)
 Figure 52. F. Hoffmann-La Roche Revenue Growth Rate in Long-term Asthma Control Medication Business (2020-2025)
 Figure 53. Merck & Co., Inc Revenue Growth Rate in Long-term Asthma Control Medication Business (2020-2025)
 Figure 54. Glenmark Pharmaceuticals Revenue Growth Rate in Long-term Asthma Control Medication Business (2020-2025)
 Figure 55. Teva Pharmaceutical Industries Revenue Growth Rate in Long-term Asthma Control Medication Business (2020-2025)
 Figure 56. Lupin Pharmaceuticals Revenue Growth Rate in Long-term Asthma Control Medication Business (2020-2025)
 Figure 57. Novartis International AG Revenue Growth Rate in Long-term Asthma Control Medication Business (2020-2025)
 Figure 58. Sunovion Pharmaceuticals Revenue Growth Rate in Long-term Asthma Control Medication Business (2020-2025)
 Figure 59. Sanofi Revenue Growth Rate in Long-term Asthma Control Medication Business (2020-2025)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS